EXPERIENCE  PRECLINA

Step into the future with PRECLINA : Leading the way in Immunology studies to rapid, cost-effective drug development solutions for the Biotech and pharmaceutical industry.

  • Hyper-speed of Drug Development
  • Critical Go/No-Go Decision
  • Synergetic Partnership
  • Supreme Cost-Efficiency

Expert-validated Modular Platform for efficacy Evaluation Services

Count on Preclina’s modular platform for cutting-edge fibrosis drug development, from efficacy evaluation to advanced MOA research with our extensive immunological expertise and specialized fibrosis knowledge, we empower you to transform complex challenges into groundbreaking success.

  • 아이콘

    SPOT-ON ACCURACY

  • 아이콘

    ROBUST CONSISTENCY

  • 아이콘

    BUDGET-SMART

  • 아이콘

    CUTTING-EDGE PLATFORM

Efficacy Pharmacology for Pulmonary Fibrosis

Innovation & Lead
Advance pulmonary fibrosis therapeutics with our global standard models

Revolutionize the therapeutic landscape for fibrotic lung diseases, including the formidable IPF.

Utilize our unparalleled efficacy pharmacology services to transcend the boundaries of current treatments and pioneer life-saving advancements.

    1. Master your research with global standard test models
    2. Empower your decisions with cutting-edge Read-outs
    1. Expect unparalleled reliability that surpasses industry standards
    2. Outpace competition with our swiftest platform

첫번째 이미지

Bleomycin-induced Lung Fibrosis (BILF) Model

Breakthrough Targeted Therapeutics Surpassing Limitations of Nintedanib

As pioneers in the optimization of BILF models for developing pulmonary fibrosis therapeutics that surpass Nintedanib and Pirfenidone, Preclina is dedicated to exceeding our clients' diverse needs in drug development with unmatched service that perfectly balances cost-effectiveness and exceptional quality.

  • Mouse BILF Model

    State-of-the-art standard models optimized for breakthrough drug development

    1. Preclina’s model with highest reproducibility, ensuring minimal inter-test variability
    2. Multifaceted interpretation through up-to-date evaluation techniques
    3. Encompassing comprehensive therapeutic formats, from small molecules to biologics

  • Rat BILF Model

    Fully compliant with different host requirements for IND approval

    1. Enhancing clinical trial entry success via a secondary model
    2. A solution for enhancing accuracy in the prediction of clinical trial success

첫번째 이미지

Patient-derived Cell-Based Assays

Comprehensive patient-derived primary cell banking for innovative drug pipelines

During technology transfer, requests for evidence of patient applicability often result in re-testing with patient-derived cells. Discover our cutting-edge solutions bridging the "death valley" between preclinical and clinical trials.

  • PreHuCel

    Premier tool featuring customized technology for drug development

    1. Banking portfolio of patient-derived cells
    2. Precious opportunities for prediction of clinical applicability
    3. Minimize late-stage failure risks through bridging the translational gap

  • PreExoCel

    Cell/tissue banking System across developmental stages of disease animal models

    1. Accelerating efficacy evaluation of hit/lead compounds through bypassing in vivo models
    2. Translational research data with ultimate cost-efficiency
    3. Practical ways to implement "Reduction" in the 3R principles of animal experimentation

첫번째 이미지

두번째 이미지

Innovative Modular Platform

No shortcut? Don't detour!

Choose Pre-Xa services

Experience Preclina's modular platform service, ensuring reliable results from reproducible BILF studies with rapid outcome delivery. We will be your pathfinder through the labyrinth of drug development with our groundbreaking solutions.

  • PreBILFi Platform

    Revolutionizing every stage with precision-optimized workflow technologies

    1. A modular platform that guarantees high-quality test results
    2. Strategic research design with expert teams at every testing stage
    3. Outstanding results with unmatched speed and exceptional quality

  • PreBILFi Premium Service

    A platform that integrates financial efficiency with pioneering technology

    1. Seamless end-to-end process from lead selection to candidate development
    2. The premier integrated platform for successful license out
    3. Advanced system with exceptional cost-efficiency

첫번째 이미지

두번째 이미지

Scleroderma Pharmacological Efficacy Assessment

An exceptional efficacy evaluation service with rare availability worldwide

Scleroderma can be partially delayed with treatments, but there are no proven anti-fibrotic drugs available. Preclina accelerates scleroderma drug development with a strategic system that utilizes an integrated portfolio of in vitro and in vivo fibrosis models along with a patient-derived biobank.

  • Bleomycin-induced Skin Fibrosis Model

    Global-standard model for scleroderma research

    1. A model with limited global availability in efficacy evaluation services
    2. The ideal model for simulating scleroderma's pathophysiology
    3. High-quality efficacy evaluation of systemic and topical treatments

  • Patient-derived Primary Cells

    Go/No-Go screening with pathologically relevant cells

    1. Cutting-edge approaches to reduce the need for retesting
    2. Ensuring high success rates in technology transfer from the start of the development stage
    3. Try the PreBISFa premium platform service

Get in touch with us to find out more
about how we can support you and your research!

Contact us